Human Recombinant Peptide Sponge Enables Novel, Less Invasive Cell Therapy for Ischemic Stroke

<div>Immunohistochemistry for GFAP. Panels (a) and (b) show the fluorescence photomicrographs of GFAP 5 weeks posttransplantation in the BMSC/direct injection (a) and BMSC/scaffold (b) groups. A red rectangle in panel (c) indicates the location. Scale bars: 500 <i>μ</i>m.</div>

Stem Cells International

fig4

Figure 4

Figure 4: Human Recombinant Peptide Sponge Enables Novel, Less Invasive Cell Therapy for Ischemic Stroke 